Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Goodwill & Intangibles (2017 - 2022)

Eledon Pharmaceuticals filings provide 1 years of Goodwill & Intangibles readings, the most recent being $1.9 million for Q4 2017.

  • On a quarterly basis, Goodwill & Intangibles changed N/A to $1.9 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.9 million, a N/A change, with the full-year FY2017 number at $1.9 million, changed N/A from a year prior.
  • Goodwill & Intangibles hit $1.9 million in Q4 2017 for Eledon Pharmaceuticals, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $1.9 million in Q2 2017 to a low of $1.9 million in Q2 2017.